Introduction to Interval Training


Written on December 11, 2023 - 10:24 pm | by admin

I am writing about interval training because enough people have written to me asking about how to combine Pilates and cardio that I thought we should look into the issue here. So far, I haven’t been very impressed with the Pilates combined cardio solutions that I’ve seen, on DVDs for example. I mean, running in place for a minute or two before doing Pilates might help get your heart rate up, but a cardio workout it’s not - even if you add flapping your arms about here and there.

My solution is to keep Pilates and cardio work separate.

Continue training!

Tags: Interval Training, Training

Merck KGaA Starts Stimuvax Phase III Study INSPIRE In Asian Patients With Advanced NSCLC


Written on December 11, 2023 - 10:54 am | by admin

Merck KGaA announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-small cell lung cancer (NSCLC). The INSPIRE(a) study will investigate if Stimuvax can extend overall survival in Asian patients with unresectable stage III NSCLC.

INSPIRE is being initiated in five Asian regions. Continue training!

Tags: Advanced, Asian Patients, Iii Study, Phase Iii Study

Pilates Exercise of the Week: Push Up on the Ball


Written on December 10, 2024 - 1:09 pm | by admin

I am thrilled to have a new online video to share with you. This week we learn Pilates push up on the ball from instructors at Movements Afoot studio in NYC.

Push up is a full-body workout. If you only have time to focus on one exercise this week, push up would be a fine choice.
Learn Push Up on the Ball

No ball yet?

Continue training!

Tags: Ball

Hope For Advanced Thymic Cancer Patients: New International Study Targets Rare Cancer


Written on December 10, 2024 - 7:07 am | by admin

The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare.

PHA-848125ac is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. It is designed to stop abnormal cell division and duplication, a common feature of cancer.

“From the initial trial in patients with advanced cancers, this drug is well tolerated. Continue training!

Tags: Cancer, Thymic Cancer